TC2N transcription was significantly lower in pheochromocytoma and paraganglioma (PCPG), skin cutaneous melanoma (SKCM), thyroid carcinoma (THCA) and uterine carcinosarcoma (UCS) (Figure 1A, Figure 1C). Here, TC2N is linked to paraganglioma.